The TCR-binding region of the HLA class I α2 domain signals rapid Fas- independent cell death: A direct pathway for T cell-mediated killing of target cells?

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4343-4352

  Pettersen, Rolf D ^a   Gaudernack, Gustav ^a   Olafsen, Mette Kløvstad ^a   Lie, Sverre O ^a   Hestdal, Kjetil ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BINDING SITES; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HYBRIDOMAS; MICE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032080393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
2. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512.
3. Davis, M. M., and P. J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395.
4. Trinchieri, G. 1994. Recognition of major histocompatibility complex class I antigens by natural killer cells. J. Exp. Med. 180:417.
5. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingarai, and L. Moretta. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619.
6. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:735.
7. Mescher, M. F. 1995. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol Rev. 146:177.
8. 3 domain of HLA-A2. Nature 345:41.
9. O'Rourke, A. M., J. Rogers, and M. F. Mescher. 1990. Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling. Nature 346:187.
10. O'Rourke, A. M., and M. F. Mescher. 1992. Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events. Nature 358:253.
11. Kane, K. P., and M. F. Mescher. 1993. Activation of CD8-dependent cytoloxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. J. Immunol. 150:4788.
12. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353.
13. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
14. Collins, T. L., P. D. Kassner, B. E. Bierer, and S. J. Burakoff. 1994. Adhesion receptors in lymphocyte activation. Curr. Opin. Immunol. 6:385.
15. Clark, W. R., C. M. Walsh, A. A. Glass, F. Hayashi, M. Matloubian, and R. Ahmed. 1995. Molecular pathways of CTL-mediated cytotoxicity. Immunol. Rev. 146:33.
16. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
17. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
18. Lowin, B., F. Beermann, A. Schmidt, and J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T lymphocyte-and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:11571.
19. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
20. Berke, G. 1995. The CTL's kiss of death. Cell 81:9.
21. Smyth, M. J., and J. A. Trapani. 1995. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 16:202.
22. Shresta, S., J. W. Heusel, D. M. Macivor, R. L. Wesselschmidt, J. H. Russell, and T. J. Ley. 1995. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol. Rev. 146:211.
23. Vujanovic, N. L., S. Nagashima, R. B. Herberman, and T. L. Whiteside. 1996. Nonsecretory apoptotic killing by human NK cells. J. Immunol. 157:1117.
24. Berke, G. 1995. PELs and the perforin and granzyme independent mechanism of CTL-mediated lysis. Immunol. Rev. 146:21.
25. Glass, A., C. M. Walsh, D. H. Lynch, and W. R. Clark. 1996. Regulation of the Fas lytic pathway in cloned CTL. J. Immunol. 156:3638.
26. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
27. Braun, M. Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
28. Geppert, T. D., M. C. Wacholtz, L. S. Davies, and P. F. Lipsky. 1988. Activation of human T4 cells by cross-linking class I MHC molecules. J. Immunol. 140:2155.
29. Houlden, B. A., S. M. Widacki, and J. A. Bluestone. 1991. Signal transduction through class I MHC by a monoclonal antibody that detects multiple murine and human class I molecules. J. Immunol. 146:425.
30. Geppert, T. D., H. Nguyen, and P. E. Lipsky. 1992. Engagement of class I major histocompatibility complex molecules by cell surface CD8 delivers an activation signal. Eur. J. Immunol. 22:1379.
31. Turco, M. C., M. De Felice, L. Corbo, G. Morrone, R. Mertelsmann, S. Ferrone, and S. Venuta. 1985. Regulatory role of a monomorphic determinant of HLA class I antigens in T cell proliferation. J. Immunol. 135:2268.
32. Taylor, D. S., P. C. Nowell, and J. Kombluth. 1986. Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation. Proc. Natl. Acad. Sci. USA 83:4446.
33. Taylor, D. S., P. C. Nowell, and J. Kornbluth. 1987. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J. Immunol. 139:1792.
34. Dasgupta, J. D., K. Cemach, D. P. Dubey, E. J. Yunis, and D. B. Amos. 1987. The role of class I histocompatibility antigens in the regulation of T-cell activation. Proc. Natl. Acad. Sci. USA 84:1094.
35. De Felice, M., M. C. Turco, P. C. Giarrusso, L. Corbo, R. Pizzano, V. Martinelli, S. Ferrone, and S. Venuta. 1987. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation. J. Immunol. 139:2683.
36. 3 domain of human MHC class I molecules. J. Immunol. 153:1054.
37. 2 domain in regulation of cell adhesion and proliferation. J. Immunol. 156:1415.
38. Ødum, N., J. A. Ledbetter, P. Martin, D. Geraghty, T. Tsu, J. A. Hansen, and P. Gladstone. 1991. Homotypic aggregation of human cell lines by HLA class II-, class Ia-and HLA-G specific monoclonal antibodies. Eur. J. Immunol. 21:2121.
39. Alcover, A., V. Juillard, and O. Acuto. 1992. Engagement of major histocompatibility complex class I and class II molecules up-regulates intercellular adhesion of human B cells via a CD11/CD18-independent mechanism. Eur. J. Immunol. 22:405.
40. 3 domain of class I MHC. Science 252:1424.
41. Woodle, E. S., D. M. Smith, J. A. Bluestone, W. M. Kirkman III, D. R. Green, and E. W. Skowronski. 1997. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J. Immunol. 158:2156.
42. + T-cell immunity to munne rotavirus in the absence of perforin, Fas and gamma interferon. J. Virol. 71:479.
43. McMichael, A. J., P. Parham, N. Rust, and F. Brodsky. 1980. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum. Immunol. 1:121.
44. Parham, P., and W. F. Bodmer. 1978. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276:397.
45. Parham, P., and F. M. Brodsky. 1981. Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3:277.
46. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
47. Russo, C., A. K. Ng, M. A. Pellegrino, and S. Ferrone. 1983. The MoAb CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18:23.
48. Pettersen, R. D., K. Hestdal, N. Lee, D. E. Geraghty, E. T. Valø S. O. Lie, and G. Gaudernack. 1995. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules. Tissue Antigens 45:203.
49. Gur, H., F. El-Zaatari, T. D. Geppert, M. C. Wacholtz, J. D. Taurog, and P. E. Lipsky. 1990. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J. Exp. Med. 172:1267.
50. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
51. Martin, S. J., C. P. M. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. A. A. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl. J. Exp. Med. 182:1545.
52. Klaus, S. J., S. P. Sidorenko, and E. A. Clark. 1996. CD45 ligation induces programmed cell death in T and B lymphocytes. J. Immunol. 156:2743.
53. Bernard, G., J.-P. Breittmayer, M. de Matteis, P. Trampont, P. Hofman, A. Senik, and A. Bernard. 1997. Apoptosis of immature thymocytes mediated by E2/CD99. J. Immunol. 158:2543.
54. Eischen, C. M., T. J. Kotte, L. M. Martins, G. S. Basi, J. S. Turg, W. C. Earnshaw, P. J. Leibson, and S. H. Kaufmann. 1997. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/ Fas ligand interactions. Blood 90:935.
55. Cohen, J. J., R. C. Duke, V. A. Fadoks, and K. S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267.
56. Hogan, K. T., C. Clayberger, E. J. Bernhard, S. F. Walk, J. P. Ridge, P. Parham, A. M. Krensky, and V. H. Engelhard. 1988. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J. Immunol. 141:2519.
57. Hogan, K. T., and S. L. Brown. 1992. Localization and characterization of serologic epitopes on HLA-A2. Hum. Immunol. 33:185.
58. Doménech, N., J. Santos-Aguado, and J. A. Lopez de Castro. 1991. Antigenicity of HLA-A2 and HLA-B7: loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80. Hum. Immunol. 30:140.
59. Salter, R. D., C. Clayberger, C. E. Lomen, A. M. Krensky, and P. Parham. 1987. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J. Exp. Med. 166:283.
60. Layet, C., B. Kahn-Perles, P. Pontarotti, P. Ferrier, J. Sire, and F. A. Lemonnier. 1987. Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis. J. Immunol. 138:2197.
61. Taketani, S., M. S. Krangel, D. Pious, and J. L. Strominger. 1983. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant. J. Immunol. 131:2935.
62. 3 domain. J. Immunol. 148:3202.
63. Fadok, V. A., J. S. Savill, C. Haslett, D. L. Bratton, D. E. Doherty, P. A. Campbell, and P. M. Henson. 1992. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol. 149:4029.
64. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.
65. Martin, S. J., D. M. Finucane, G. P. Amarante-Mendes, G. A. O'Brien, and D. R. Green. 1996. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:28753.
66. + cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 92:11990.
67. Nishioka, W. K., and R. M. Welsh. 1994. Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J. Exp. Med. 179:769.